Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02200055 · ClinicalTrials.gov registry record · NA

Using Electrical Bioimpedance Assessments to Estimate Perioperative Total Body Water and Postoperative Fluid Need

A NA study, sponsored by United States Naval Medical Center, Portsmouth.

Completed
Registry status
NA
Development phase
86
Enrollment target

NCT02200055 is a NA study that has completed, run by United States Naval Medical Center, Portsmouth. The registered enrollment target is 86 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02200055, a NA study, has completed, sponsored by United States Naval Medical Center, Portsmouth.

COMPLETED
Registry status
NA
Development phase
86 participants
Enrollment target

Study Summary

Being able to accurately monitor patient bodily fluid levels during and after surgery is very important, as there are a number of complications that can arise if a patient's fluid levels become unbalanced, such as swelling within or pressure on various bodily organ systems. There are several different ways that physicians can monitor a patient's fluid balance during and after surgery, such as measuring the amount of urine output or the use of central venous catheters which measure the pressure in the veins entering the heart. Most of these techniques are invasive since they require tubes to be inserted into the body. A potential alternative would be to use a noninvasive technique such as electrical bioimpedance (BIA). Bioimpedance assessments work by using small electrical currents that can accurately predict both the water surrounding the outside of cells in the body, as well as the total amount of water in the entire body. Electrical bioimpedance assessments have been used to estimate patient swelling following surgery (edema), to measure the volume of blood the heart is pumping out, as well as to calculate body fat percentages. The goal of this study is to relate this technology to fluid shifts within the body that occur as a result of surgery, in particular, major intra-abdominal surgeries. By using bioimpedance during and after surgery, the investigators will compare the data collected with that calculated by using traditional measures of body fluid status, such as urine output and intraoperative blood loss. During the study, the bioimpedance monitors will not replace the standard bodily fluid monitors and will not interfere with their readings. Additionally, the electrical current produced by the bioimpedance monitors is too small for patients to feel and will not interfere with medical devices such as pacemakers.

Interventions

  • DEVICE Bodystat Quadscan 4000

Trial Details

FieldValue
Enrollment Target 86 participants
Start Date 2012-05
Est. Completion 2015-07
Phase NA

What the Registry Record Tells You About NCT02200055

The ClinicalTrials.gov registry entry for NCT02200055 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is United States Naval Medical Center, Portsmouth, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Bodystat Quadscan 4000 is the first listed.

NCT02200055 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02200055 about?

NCT02200055 is a clinical study titled "Using Electrical Bioimpedance Assessments to Estimate Perioperative Total Body Water and Postoperative Fluid Need". Being able to accurately monitor patient bodily fluid levels during and after surgery is very important, as there are a number of complications that can arise if a patient's fluid levels become unbalanced, such as swelling within or pressure on various bodily organ systems. There are several differe...

What is the current status of trial NCT02200055?

This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2012-05. Estimated completion is 2015-07.

What interventions are being tested in trial NCT02200055?

The interventions under investigation include: Bodystat Quadscan 4000 (DEVICE).

Who is sponsoring clinical trial NCT02200055?

This trial is sponsored by United States Naval Medical Center, Portsmouth, which has 7 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.